Grifols is a recognized leader in transfusion medicine with a comprehensive portfolio of products designed to support safety from donation through transfusion.
Our Procleix NAT solutions deliver high-quality, fully automated and integrated blood screening to your laboratories – from community blood centers to consolidated testing facilities around the world. With more worldwide placements than any other NAT provider, Procleix platforms screen more donors globally than any other NAT blood screening solution.2
The Procleix Panther system expands your laboratory's capabilities to anticipate the blood screening needs of today and tomorrow with a continuously expanding assay menu.
- Release first reportable results in 3.5 hours, then 5 additional results every 5 minutes
- Features built-in process controls for sample and results integrity
- Easy-to-use fully integrated and automated system
- User-friendly software with a task-driven touchscreen interface
- Continuous or batch processing
- Random access and STAT capabilities
Our blood typing products cover the main needs of immunohematology laboratories. They offer a solution for each testing need and laboratory workflow with the expert support of a specialized global partner so that patients receive timely and safe transfusions.
The new Erytra Eflexis: Adaptability that fits your lab
The new Erytra Eflexis3 – the natural evolution in Grifols scalable, blood typing solutions.
This truly flexible system allows laboratories to select the solution that is best suited to different workflow needs and capacities.
The Erytra and Erytra Eflexis are true scalable systems that offer different throughput and capacities, while using the same reagents and sharing the equivalent software suite. Therefore you can select the solution that is best suited for your laboratory.
[insert image of Erytra and Eflexis here]
An innovative card based on lateral-flow technology that enables extensive red cell typing in just a few minutes.
- Several cards for forward ABO blood group, Rh(D), Rh phenotype, and K in only 5 minutes
- One new card for six rare phenotypes, including Duffy, Kidd, and Ss in only 8 minutes
[insert image of MDmulticard Basic Extended Phenotype]
The new ID RHD XT4 product expands our BLOODchip portfolio for blood group genotyping for more testing capabilities.
- Employ the same easy-to-use technology5 as the ID CORE XT6 products for red blood cell antigens and ID HPA XT7 for human platelet antigens
- Designed for detection of relevant RhD variants
[insert image of ID CORE XT]
1This product is in development and is not available for commercial sale. The final performance characteristics and features of the product may be subject to change
2Market data on file.
3 The Erytra Eflexis analyzer is CE marked in accordance with the Directive EC of the European Parliament and of the Council of October on in vitro diagnostic medical devices. This product is not available for commercial sale in Canada. It is intended for healthcare professionals only. Product registration and availability vary by country. To know whether the Erytra Eflexis system is available for sale in your country, please contact your local Grifols representative.
4The ID RHD XT is CE marked in accordance with the Directive EC of the European Parliament and of the Council of October on in vitro diagnostic medical devices. Product registration and availability vary by country. To know whether the ID RHD XT is available for sale in your country, please contact your local Grifols representative.
5Based on Luminex® technology.
6,7 ID CORE XT and ID HPA XT are CE marked and; in the US, is for research use only and not for use in diagnostic procedures.